Barrett’s Research
Analysis 8 min read·

NAD+ Protocol: Why a Clinic Protocol Is Not a Trial

An NAD+ protocol from a clinic and a trial protocol share a word and almost nothing else. One binds its authors in advance. The other is a schedule of invoices.

By Rihab Yassin, Ph.D. · Health Technology Researcher & Publisher

Our pick, and the reason

Ascension Peptides for NAD+

No prescription route exists for NAD+ anywhere, so this is research material: US-based, independently tested, half price with the code.

NAD+ · 1,000 mg$104.00$52.00Get the 1,000 mg →

Quoted per 100 mg because NAD+ is dosed in hundreds of milligrams, not the single milligrams a peptide vial holds. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.

Code at checkoutPEPTIDEDECK50% off
  • Two outside labs test every batch
  • Free shipping over $250
  • Same-day dispatch before 2pm CST
The short version8 min read

The NAD+ protocol emailed to you after a consultation usually runs to a page and a half. A loading course of several sessions close together, a rate, a maintenance session at some interval afterwards, occasionally a short list of references at the bottom. It looks like a treatment plan, and it is formatted like one.

The page and a half you were emailed, read as a document

The same word, in research, names a document that has to exist before a single participant is approached, that is registered publicly, and that its authors are then held to. Understanding the difference between those two objects is most of what a person needs to evaluate the one in their inbox.

Set aside for a moment whether the plan is a good idea and ask a narrower question: what does this document oblige anyone to do?

It commits you to a series of appointments and to paying for them. It commits the provider to supplying those appointments. It does not commit anyone to a definition of success, to a point at which the plan is abandoned, to recording what happens, or to telling anybody the result. If you finish the course and feel exactly as you did before, nothing in the document has been contradicted, because nothing in it made a prediction.

That is not a hidden flaw. It is what the genre is. A service schedule is a perfectly honest thing for a business to produce. The problem starts when it is read as though it belonged to the other genre.

Why an NAD+ protocol binds nobody to anything

The features that give a research protocol its authority are all absent, and each absence is worth naming rather than gesturing at.

There is no comparison group, so any change you notice has nothing to be compared against except your own memory. There is no blinding, so both you and the person charging you know what you received. There is no outcome named before you started, so the result can be judged afterwards against whatever ended up looking best. There is no registration, so no external record exists of what was planned. There is no analysis plan, no independent monitoring, no ethics review of the risk you are taking, and no obligation to publish anything at all.

Remove all of that and what is left is a plan of purchases. It may still be a plan you want. It carries no evidential weight, and it cannot generate any.

Prespecification is the thing a menu cannot fake

The single feature doing the most work in a real protocol is that it is written first.

Deciding in advance what will be measured, in whom, over what period, and what would count as a failure, is what stops a study from finding whatever it hoped to find. It is an unglamorous administrative act and it is the reason trial results carry weight that clinical impressions do not. It cannot be added afterwards, and it cannot be simulated by formatting.

A clinic plan is written after the sale is agreed, describes what will be sold, and names no outcome it could fail to reach. However carefully it is typed, and however well qualified its author, it began at the wrong end of the sequence.

The two documents, obligation by obligation

The last row is the one people notice least and it changes the incentives of every row above it.

ObligationRegistered trial protocolPlan emailed by a provider
Written before anyone is exposedRequiredWritten after the consultation
Publicly registeredRequired in the systems that matterNo
Primary outcome named in advanceRequiredAbsent
Comparison groupSpecified, usually placebo controlledNone
Reviewed by an ethics committeeRequiredNo
Independent safety monitoringUsual for anything invasiveThe practice monitors itself
Results reported whichever way they fallExpected, and increasingly enforcedNothing is reported
Who bears the costThe sponsorYou

The loading course, and the arithmetic underneath it

Almost every plan in this market opens with a run of closely spaced sessions before settling into something slower. The shape is borrowed from real pharmacology, where a loading phase exists because a drug with a known half life takes a predictable time to reach a steady concentration, and the loading amount is calculated from that.

Here the borrowing keeps the shape and drops the calculation. For the injected coenzyme in humans there is no published work establishing what is reached, how long it persists, or what would count as steady. The interval was not derived. It was chosen, and it happens to front load the revenue of the course.

That may be uncharitable in an individual case. Some providers space sessions closely because clients report feeling better that way, which is a reason, if not a strong one. It is not a reason drawn from the compound's behaviour in people, because that information has not been generated.

What happens when you report back that nothing changed

Watch what the document does with a negative result, because this is where the difference from a trial becomes concrete rather than theoretical.

You finish the loading course and feel no different. In a trial, that outcome was defined before you enrolled, it goes into the analysis, and it counts against the intervention whether anyone likes it or not. There is no version of the study in which your result is quietly reinterpreted.

In a clinic, the same report has several available answers and none of them is written down in advance. You may be told that the loading phase needs extending. That responses vary and yours is slower. That a maintenance schedule is where the benefit accumulates. That your baseline was lower than expected. Every one of these can be said sincerely by a clinician who believes it, and every one of them converts a disconfirming result into a reason to continue.

That structure is what philosophers of science mean by a claim that cannot fail. It is not evidence of bad faith. It is a property of a document with no prespecified outcome, and it will behave this way even in the hands of the most scrupulous provider.

The practical test is worth applying before you start rather than after. Ask, at the first appointment, what result after the loading course would make them recommend stopping. A provider who has an answer, and who names something specific and checkable, has given you a version of prespecification that the document itself does not contain. A provider whose answer is that a lack of response means more sessions has told you the plan cannot be wrong.

The part of the bill that buys something real

None of this makes a clinic worthless, and pretending otherwise would be its own kind of dishonesty.

What you are buying that has value: a trained person taking a history, who may spot that your tiredness has a cause worth investigating properly. Someone who checks your medication list. Sterile technique and a cannula placed by somebody who does it regularly. A room with a person in it who will notice if you react badly and stop. Insurance, and a complaints route that leads somewhere.

What the fee cannot buy, at any price: an approved use, a verified product, a defined amount, a leaflet listing known harms, a recall mechanism, or a reporting system that will record your experience so that the next person benefits from it. Those are functions of a regulatory system, not services a practice can generate.

A provider who tells you which column each part of their offer sits in is being straight with you. That is a better signal than anything in the document itself.

Frequently Asked Questions

It gives the encounter professional accountability, which is real. It does not convert a service schedule into evidence, because the qualification attaches to the clinician's conduct rather than to the content of an unapproved plan.
Only if the references studied the thing being sold. In this category most cited human work gave people an oral precursor rather than an infusion, so the list supports a field and not the plan above it.
Neither is wrong against a standard, because no standard exists to be wrong against. The disagreement is itself the finding: where a licensed medicine has a defined regimen, plans converge, and where nothing has been defined, they scatter.
A follow up lets someone ask how you are and act if you are unwell, which is worth having. Monitoring in the trial sense means measuring a prespecified outcome against a comparison group, and a review appointment does not do that.
Asking is reasonable. The more useful request is for the reasoning: what this interval is based on, what would make them stop, and what they would expect to see if it were not working. The answers tell you more than the document does.

From all of us at Barrett's Research: this is friendly, educational information, not medical advice. The figures here are seed data, so please double-check them and talk with your own clinician before you start or change any medication.

Related Resources

2-minute match quiz

Not sure which program is the right fit?

Answer six quick questions and we'll point you to the programs that suit your budget, your insurance, and how you want to be cared for.